PharmAla Biotech Logo 800 x 422.png
PharmAla Partners with Clariti Strategic Advisors™
November 08, 2023 08:55 ET | PharmAla Biotech
PharmAla signs long-term partnership with Clariti Strategic Partners as its investment banking and advisory firm
PharmAla Biotech Logo 800 x 422.png
PharmAla Completes Historic First Shipment of MDMA and Psilocybin to Cortexa
November 07, 2023 08:55 ET | PharmAla Biotech
PharmAla completes the historic first shipment of MDMA and Psilocybin to its Australian Joint Venture, Cortexa, for use in commercial patient treatments
PharmAla Biotech Logo 800 x 422.png
PharmAla Receives First Office Action for PharmAla-1 PCT Filing
September 25, 2023 08:55 ET | PharmAla Biotech
PharmAla has recieved a positive First Office Action on its novel P-1 Molecule from the Patent Cooperation Treaty
PharmAla Biotech Logo 800 x 422.png
PharmAla Begins Trading on OTCQB
September 06, 2023 08:55 ET | PharmAla Biotech
VANCOUVER, British Columbia, Sept. 06, 2023 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTCQB:PMBHF), a biotechnology company focused on the...
PharmAla Biotech Logo 800 x 422.png
PharmAla Ships MDMA to Mind Medicine Australia and Orygen Institute
August 10, 2023 08:30 ET | PharmAla Biotech
VANCOUVER, British Columbia, Aug. 10, 2023 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:PMBHF), a biotechnology company focused on the research,...
PharmAla Biotech Logo 800 x 422.png
PharmAla Files Patent for Novel MDXX Molecule PharmAla-1
July 31, 2023 08:30 ET | PharmAla Biotech
VANCOUVER, British Columbia, July 31, 2023 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:PMBHF), a biotechnology company focused on the research,...
PharmAla Biotech Logo 800 x 422.png
PharmAla Received Guidance on ALA-002 from MHRA; Launches Clinical Program with University of Sydney
July 20, 2023 09:07 ET | PharmAla Biotech
VANCOUVER, British Columbia, July 20, 2023 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:PMBHF), a biotechnology company focused on the research,...
PharmAla Biotech Logo 800 x 422.png
Cortexa Makes First Drug Order for Australian Commercial Market
July 04, 2023 08:55 ET | PharmAla Biotech
VANCOUVER, British Columbia, July 04, 2023 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:PMBHF), a biotechnology company focused on the research,...
PharmAla Biotech Logo 800 x 422.png
PharmAla Biotech Receives Export Permit to Ship GMP LaNeo MDMA to the University of Sydney
June 16, 2023 09:00 ET | PharmAla Biotech
VANCOUVER, British Columbia, June 16, 2023 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:PMBHF, a biotechnology company focused on the research,...
PharmAla Biotech Logo 800 x 422.png
PharmAla Biotech announces Non-Brokered Private Placement Offering of up to an Aggregate of $5,000,000
June 12, 2023 20:07 ET | PharmAla Biotech
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, June 12, 2023 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (the...